Carriba et al. [88] demonstrated changes in TNFα signaling components in postmortem bran samples from individuals with no AD histopathological alterations (Braak 0), asymptomatic subjects with some AD histopatholical modification (Braak II), and demented AD patients (Braak V and VI). Here, TNF is linked to Alzheimer disease.